Ajanta Pharma Ltd has informed that the members at the 28th Annual General Meeting (AGM) of the Company held on September 28, 2007, inter alia, have accorded to the following:
1. Adoption of the Profit and Loss Account for the year ended March 31, 2007 and the Balance Sheet as on that date together with the reports of the Directors and Auditors thereon.
2. Declaration of Dividend at the rate of 20% on the Equity Shares.
3. Re-appointment of Mr. Madhusudan B Agrawal & Mr. Madhukar as Directors of the Company.
4. Re-appointment of M/s. Kapoor & Parekh Associates, Chartered Accountants, Mumbai as Auditors of the Company to hold office till the conclusion of the next Annual General Meeting of the Company on remuneration, terms & conditions.
6. Appointment of Mr. Ravi P Agrawal as President - Business Development and to hold an office or place of profit in the Company w.e.f. April 01, 2007, for a period of 5 years on remuneration, terms & conditions.
7. Appointment of Mr. Rajesh M Agrawal, as President - Latin America & Asia and to hold an office or place of profit in the Company w.e.f. April 01, 2007, for a period of 5 years on remuneration, terms & conditions.
Subscribe to:
Post Comments (Atom)
1 comment:
MAXIDEX WARNING
I had eye surgery and in the post-o p pack was MAXIDEX(dexamethasone) drops by ALCON LABS.
Two days later I was BLIND
Use Google and enter EPOCRATES MAXIDEX to verify
Post a Comment